Page last updated: 2024-08-17

phenidone and Experimental Mammary Neoplasms

phenidone has been researched along with Experimental Mammary Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aldossary, SA; Ansari, MN; Gautam, S; Kaithwas, G; Rani, S; Saeedan, AS1

Other Studies

1 other study(ies) available for phenidone and Experimental Mammary Neoplasms

ArticleYear
Effects of phenidone (DuCLOX-2/5 inhibitor) against N-methyl-N-nitrosourea induced mammary gland carcinoma in albino rats.
    Toxicology and applied pharmacology, 2018, 07-15, Volume: 351

    Topics: Animals; Arachidonate 5-Lipoxygenase; Cyclooxygenase 2 Inhibitors; Female; Lipoxygenase Inhibitors; Mammary Neoplasms, Experimental; Methylnitrosourea; Pyrazoles; Random Allocation; Rats; Rats, Wistar; Treatment Outcome

2018